AI MARKET SCANNING

Gossamer Bio Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +0.02%
MAX GAP RECORD -11.76%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $GOSS
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 13, 2026 Earnings Release 2026-08-13 (BEFORE OPEN)
-1.12%
May 15, 2026 Earnings Release 2026-05-15 (AFTER CLOSE)
-11.76%
Mar 17, 2026 Earnings Release 2026-03-17 (AFTER CLOSE)
-2.97%
Nov 05, 2025 Earnings Release 2025-11-05 (AFTER CLOSE)
-3.71%
Aug 05, 2025 Earnings Release 2025-08-05 (AFTER CLOSE)
+0.93%
May 15, 2025 Earnings Release 2025-05-15 (AFTER CLOSE)
+0.00%
Mar 13, 2025 Earnings Release 2025-03-13 (AFTER CLOSE)
+3.08%
Nov 07, 2024 Earnings Release 2024-11-07 (AFTER CLOSE)
-1.92%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.5%
Bullish Gaps (7)
Bearish Gaps (6)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $GOSS

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗